Editorial Board

	Editor-in-Chief Aaron E. Miller, MD, FAAN New York, New York Relationship Disclosure: Dr. Miller has received personal compensation for activities with Acorda Therapeutics, Inc., Biogen Idec, BioMarin Pharmaceutical Inc., Daiichi Sanyko Company, Ltd., EMD Serono, Inc., GlaxoSmithKline, Merck & Co., Inc., Novartis, Ono Pharmaceutical Co, Ltd., Pfizer Inc, Sanofi-Aventis, and Teva Neuroscience as a consultant and speaker. Dr. Miller has received personal compensation from the AAN for serving as the editor of Continuum: Lifelong Learning in Neurology and from Lippincott Williams & Wilkins for serving as an editorial advisory board member for Real Living with Multiple Sclerosis. Dr. Miller has received research support from Acorda Therapeutics, Inc., Biogen Idec, Genzyme Corporation, Immune Tolerance Network, Sanofi-Aventis, and Teva Neuroscience.
	Associate Editor Steven L. Lewis, MD, FAAN Chicago, Illinois Relationship Disclosure: Dr. Lewis has received personal compensation in an editorial capacity for Neurology.
	Associate Editor of Ethics Michael A. Williams, MD, FAAN Baltimore, Maryland Relationship Disclosure: Dr. Williams' life partner holds stock in Ecolab, General Electric Company, Life Technologies Corporation, Medtronic Corporation, and Pfizer Inc.
	Associate Editor of Practice Larry B. Goldstein, MD, FAAN Durham, North Carolina Relationship Disclosure: Dr. Goldstein has received personal compensation for serving on committees from Abbott Laboratories, AGA Medical Corporation, and Pfizer Inc; for serving as a consultant from Allergan, Inc., and Boeringer Ingelheim; and for speaking from Bayer. Dr. Goldstein has received research support from AGA Medical Corporation.

Editorial Board

Viveca Bhat, MD, San Antonio, Texas
Relationship Disclosure: Dr. Bhat has nothing to disclose.

Kersti Bruining, MD, FAAN, Traverse City, Michigan
Relationship Disclosure: Dr. Bruining has nothing to disclose.

Cynthia L. Comella, MD, FAAN, Chicago, Illinois
Relationship Disclosure: Dr. Comella has received personal compensation for consulting activities from Allergan, Inc., Boehringer Ingelheim, Eisai Inc., Ipsen, Merz Pharmaceuticals Inc., UCB, and Valeant Pharmaceuticals. Dr. Comella has received research support in the form of grants to her institution from Allergan, Inc., Boeringer Ingelheim, Dystonia Study Group, Ipsen, Merz Pharmaceuticals Inc., National Institutes of Health, and Parkinson Study Group.

Matthew E. Fink, MD, New York, New York
Relationship Disclosure: Dr. Fink has received personal compensation as a consultant from Novartis and as an editor for Neurology Alert. Dr. Fink's compensation and/or research work has been funded entirely or in part by a grant to his university from a governmental organization.

Carlayne E. Jackson, MD, FAAN, San Antonio, Texas
Relationship Disclosure: Dr. Jackson has received personal compensation for serving on scientific advisory boards from Avanir Pharmaceuticals, Inc., and Sanofi-Aventis and has received research support from Cytokinetics, Inc., and Knopp Neurosciences, Inc.

Christina M. Marra, MD, FAAN, Seattle, Washington
Relationship Disclosure: Dr. Marra has nothing to disclose.

Laszlo Mechtler, MD, Amherst, New York
Relationship Disclosure: Dr. Mechtler has received personal compensation for speaking engagements from Cerenex Pharmaceuticals, GlaxoSmithKline, Merck & Co., Inc., Ortho-McNeil, Pfizer Inc, and UCB.

Jonathan W. Mink, MD, PhD, FAAN, Rochester, New York
Relationship Disclosure: Dr. Mink has received personal compensation for serving as an associate editor of Neurology. Dr. Mink's compensation and/or research work has been funded entirely or in part by grants to his university from a governmental organization and a nonprofit tax-exempt organization.

Jennifer R. Molano, MD, Nashville, Tennessee
Relationship Disclosure: Dr. Molano has nothing to disclose.

Joel R. Saper, MD, FAAN, Ann Arbor, Michigan
Relationship Disclosure: Dr. Saper has received personal compensation for serving on scientific advisory boards from Allergan, Inc., Neuralieve Inc., and St. Jude Medical, Inc., and for speaking engagements from Merck & Co., Inc., Otho-McNeil Neurologics, and Purdue Pharma. Dr. Saper or his immediate family holds stock in Pozen Inc., greater than 5 percent of the company or greater than $10,000 in value. Dr. Saper has received research support from Boston Scientific Corporation, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson Services, Inc., Merck & Co., Inc., Neuraxon, NuPathe Inc., St. Jude Medical, Inc., and Zogenix, Inc.

Mark J. Tullman, MD, New York, New York
Relationship Disclosure: Dr. Tullman has received personal compensation for consulting and speaking engagements from Acorda Therapeutics Inc,, Biogen Idec, EMD Serono, Inc., Novartis, Pfizer Inc, Sanofi-Aventis, Teva Neuroscience, and Vaccinex, Inc. Dr. Tullman has received research support from Acorda Therapeutics, Inc., BioMS Medical Corporation, Genentech, Inc., and Novartis.

Charles Zollinger, MD, Canton, Ohio
Relationship Disclosure: Dr. Zollinger has nothing to disclose.

Founding Editor

Elliott L. Mancall, MD, FAAN (1993-2002)

Founding Program Director

Theodore L. Munsat, MD, FAAN

Education Committee Relationship Disclosures
Imran I. Ali, MD, FAAN, has received personal compensation for activities with GlaxoSmithKline, Cyberonics, and UCB as a consultant or speaker, and has received research support from UCB. Peter R. Bergethon, MD, has nothing to disclose. Allison Brashear, MD, FAAN, has received personal compensation for activities with Allergan, Inc., Merz, Ipsen, and Osmotica as a consultant, has received personal compensation in an editorial capacity for Wemove, and has received research support from Allergan, Inc., Merz, and Ipsen. Cynthia L. Comella, MD, FAAN, see above. John W. Engstrom, MD, FAAN, has nothing to disclose. Charles C. Flippen, II, MD, FAAN, has received personal compensation for activities with GlaxoSmithKline, Merck &Co., Inc., Ortho McNeil, and Pfizer Inc., as a member of their speaker bureaus, and has received personal compensation in an editorial capacity for Journal Watch Neurology. Frederick G. Flynn, DO, FAAN, has nothing to disclose. Jonathan P. Hosey, MD, FAAN, has nothing to disclose. Steven L. Lewis, MD, FAAN, see above. Jennifer R. Molano, MD, see above. John C. Morgan, MD, PhD, has received consulting fees, and/or research grants, and/or speaking honoraria from Boehringer Ingelheim, CSRA Parkinson Support Group, GlaxoSmithKline, Huntington Study Group, National Parkinson Foundation, Novartis, Teva Neuroscience, and USF Continuing Education. Mark L. Moster, MD, FAAN, has received personal compensation for activities with Biogen Idec as a lecturer. Joseph E. Safdieh, MD, has nothing to disclose. Pradeep K. Sahota MD, FAAN, has nothing to disclose. Joseph I. Sirven, MD, FAAN, has received personal compensation for activities with UCB. A. Gordon Smith, MD, has received personal compensation for activities with Allergan, Inc., Solstice Neurosciences, and NeurogesX as a consultant. Barney J. Stern, MD, FAAN, has received personal compensation in an editorial capacity for The Neurologist, has received compensation and/or his research work has been funded entirely or in part by a grant to their university. The grant agreement requires that the name of the funding entity and the purpose of the grant may not be disclosed. The funding entity is a governmental organization. Susan Rodmyre has nothing to disclose.

Program Accreditation and Development Subcommittee Relationship Disclosures
Pradeep K. Sahota MD, FAAN, see above. Allison Brashear MD, FAAN, see above. J. Clay Goodman MD, FAAN, has nothing to disclose. Steven L. Lewis MD, FAAN, see above. Barbara F. Westmoreland MD, FAAN, has nothing to disclose. Susan Rodmyre, see above.

Editorial Office

Continuum: Lifelong Learning in Neurology
American Academy of Neurology
1080 Montreal Avenue
St. Paul, MN 55116
Phone: (651) 695-1940
(800) 879-1960